PMID: 7539825Jan 1, 1994Paper

Granulocyte-macrophage colony-stimulating factor mimicry and receptor interactions

Immunologic Research
J M Von FeldtW V Williams

Abstract

Development of small molecular mimics of larger polypeptide ligands is an important approach to pharmacophore design. One strategy for the development of such mimics is analysis of alternative ligands that bind to the same site as the native ligand. These allow examination of the structural and chemical constraints for binding within the setting of diverse backbone geometries. The use of antireceptor antibodies as alternative ligands has allowed the development of biologically active peptides in several ligand-receptor systems. This technology has been applied to the study of interactions between human granulocyte-macrophage colony-stimulating factor (GM-CSF) and its receptor (GM-CSFR). GM-CSF is one of a family of signal-transducing cytokines and growth factors characterized by a four-helix bundle core structure. The GM-CSFR is comprised of an alpha-chain (GM-CSFR alpha) specific for GM-CSF, and a beta-chain (beta c) shared with the interleukin-3 and interleukin-5 receptors. At least two sites on GM-CSF have been implicated in the GM-CSF-GM-CSFR alpha/beta c ternary complex. In studies summarized here, synthetic peptide analogs of GM-CSF sequences were designed and used to map neutralizing epitopes. One neutralizing epitope co...Continue Reading

References

Dec 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M W PrideY Thanavala
Apr 1, 1992·DNA and Cell Biology·J M Von FeldtW V Williams
Apr 20, 1992·Journal of Molecular Biology·L J SmithC M Dobson
Jan 1, 1991·Bulletin du cancer·J BanchereauF Rousset
Dec 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·K HayashidaA Miyajima
Sep 5, 1991·Journal of Molecular Biology·K DiederichsP A Karplus
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·S A CannistraJ D Griffin
Sep 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·C BruckM I Greene
Sep 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·W V WilliamsM I Greene
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·W V WilliamsM I Greene
Aug 1, 1989·Journal of Neurochemistry·C RomanoP B Molinoff
Jul 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·A B Shanafelt, R A Kastelein
May 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K KaushanskyJ W Adamson
Dec 18, 1987·Science·B J BrandhuberD B McKay
Jul 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·F LeeD Rennick
May 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·M LeviB Wahren

❮ Previous
Next ❯

Citations

Feb 9, 1996·The Journal of Biological Chemistry·C MonfardiniW V Williams

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.